Arizona Republican Sen. John McCain has been diagnosed with an aggressive form of brain cancer called a glioblastoma, and his office said he’s exploring treatment options.
For now, those are slim, but there are a few promising therapies in the works, according to Johns Hopkins Medicine researchers.
One of them is a veterinary drug mebendazole that had been used to deworm the mice used in the cancer lab. It prolonged the rodents’ lives by months and the researchers now are exploring how to produce bigger effects, said Dr. Gregory Riggins, a Hopkins professor of neurosurgery and oncology who is preparing for the second phase of clinical trials.
Dr. Riggins and his team, along with ABC2, are actively raising funds for the phase 2 trial. ABC2 helped fund the phase 1 clinical trial in adults.
CLICK HERE for the full article by Meredith Cohn of The Baltimore Sun.